Skip to main content
. 2020 Jun 15;31(5):e74. doi: 10.3802/jgo.2020.31.e74

Table 2. Oncologic and reproductive outcomes.

Case # Oncologic outcome at Relapse (mo) Second cancer (mo*) Attempting to conceive Pregnancy Follow-up (mo) Current status
6 mo 9 mo 12 mo
1 Progression - - - - - - 119 NED
2 Persistence CR CR Endometrial (4) - Yes - 29 NED
3 Persistence Persistence CR - - Yes 1 NFTD 139 NED
4 Progression - - - - - - 106 NED
5 CR CR CR Endometrial (28) - Yes - 93 NED
6 CR CR CR - - Yes - 24 NED
7 CR CR CR Endometrial (6) - - - 48 NED
8 Persistence Persistence CR§ - - Yes (ART) - 19 NED
9 Persistence Persistence Progression - - - - 21 NED
10 CR CR CR Endometrial (21) - - - 119 NED
11 CR CR CR Endometrial (32) Ovarian (37) - - 80 NED
12 Persistence CR CR Endometrial (17) - - - 131 NED
13 CR CR CR Endometrial (142) - - - 148 NED
14 CR CR CR - - Yes 1 NFTD 30 NED
15 CR CR CR - - Yes 1 NFTD; 2 SFTM 35 NED
16 CR CR CR - - Yes (ART) - 44 NED
17 CR CR CR - - - - 18 NED
18 Persistence Persistence CR - - Yes - 26 NED
19 Progression - - - Ovarian (6) - - 15 NED
20 Persistence CR CR - - Yes - 23 NED
21 Persistence - - - - - - 9 NED
22 Persistence Progression - Retroperitoneal (12) - - - 31 AWD
23 Persistence Persistence CR§ - - - - 64 NED

ART, assisted reproduction technology; AWD, alive with disease; CR, complete regression; NED, no evidence of disease; NFTD, normal full-term delivery; SFTM, spontaneous first-trimester miscarriage.

*After endometrial cancer diagnosis; Definitive surgery at 3 months; Submitted to definitive surgery; §CR at 13 months; Definitive surgery at 6 months.